1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
2
|
Yang L, Parkin DM, Li L and Chen Y: Time
trends in cancer mortality in China: 1987–1999. Int J Cancer.
106:771–783. 2003. View Article : Google Scholar : PubMed/NCBI
|
3
|
Ramalingam SS, Owonikoko TK and Khuri FR:
Lung cancer: new biological insights and recent therapeutic
advances. CA Cancer J Clin. 61:91–112. 2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Toyooka S, Mitsudomi T, Soh J, et al:
Molecular oncology of lung cancer. Gen Thorac Cardiovasc Surg.
59:527–537. 2011. View Article : Google Scholar : PubMed/NCBI
|
5
|
Calin GA, Sevignani C, Dumitru CD, et al:
Human microRNA genes are frequently located at fragile sites and
genomic regions involved in cancers. Proc Natl Acad Sci USA.
101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
6
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
7
|
Engels BM and Hutvagner G: Principles and
effects of microRNA-mediated post-transcriptional gene regulation.
Oncogene. 25:6163–6169. 2006. View Article : Google Scholar : PubMed/NCBI
|
8
|
Van Rooij E, Purcell AL and Levin AA:
Developing microRNA therapeutics. Circ Res. 110:496–507. 2012.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Lagos-Quintana M, Rauhut R, Lendeckel W
and Tuschl T: Identification of novel genes coding for small
expressed RNAs. Science. 294:853–858. 2001. View Article : Google Scholar : PubMed/NCBI
|
10
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Iorio MV, Ferracin M, Liu CG, et al:
MicroRNA gene expression deregulation in human breast cancer.
Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
12
|
Chan JA, Krichevsky AM and Kosik KS:
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
Cancer Res. 65:6029–6033. 2005. View Article : Google Scholar : PubMed/NCBI
|
13
|
Takamizawa J, Konishi H, Yanagisawa K, et
al: Reduced expression of the let-7 microRNAs in human lung cancers
in association with shortened postoperative survival. Cancer Res.
64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
14
|
Volinia S, Calin GA, Liu CG, et al: A
microRNA expression signature of human solid tumors defines cancer
gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Kosaka N, Takeshita F, Yoshioka Y and
Ochiya T: Therapeutic application of microRNAs in cancer. RNA
Interference from Biology to Therapeutics. Howard KA: Springer; New
York, NY: pp. 299–314. 2013, View Article : Google Scholar
|
16
|
Shenouda SK and Alahari SK: MicroRNA
function in cancer: oncogene or a tumor suppressor? Cancer
Metastasis Rev. 28:369–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
17
|
Li D, Liu X, Lin L, et al: MicroRNA-99a
inhibits hepatocellular carcinoma growth and correlates with
prognosis of patients with hepatocellular carcinoma. J Biol Chem.
286:36677–36685. 2011. View Article : Google Scholar : PubMed/NCBI
|
18
|
Cui L, Zhou H, Zhao H, et al: MicroRNA-99a
induces G1-phase cell cycle arrest and suppresses tumorigenicity in
renal cell carcinoma. BMC Cancer. 12:5462012. View Article : Google Scholar : PubMed/NCBI
|
19
|
Gao W, Shen H, Liu L, et al: MiR-21
overexpression in human primary squamous cell lung carcinoma is
associated with poor patient prognosis. J Cancer Res Clin Oncol.
137:557–566. 2011. View Article : Google Scholar
|
20
|
Fong KM, Sekido Y, Gazdar AF and Minna JD:
Lung cancer 9; Molecular biology of lung cancer: clinical
implications. Thorax. 58:892–900. 2003. View Article : Google Scholar : PubMed/NCBI
|
21
|
Raveche ES, Salerno E, Scaglione BJ, et
al: Abnormal microRNA-16 locus with synteny to human 13q14 linked
to CLL in NZB mice. Blood. 109:5079–5086. 2007. View Article : Google Scholar : PubMed/NCBI
|
22
|
Hatley ME, Patrick DM, Garcia MR, et al:
Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21.
Cancer Cell. 18:282–293. 2010. View Article : Google Scholar : PubMed/NCBI
|
23
|
Huang Z, Huang S, Wang Q, et al:
MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1
in human colorectal carcinoma. Cancer Res. 71:2582–2589. 2011.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Chiyomaru T, Yamamura S, Fukuhara S, et
al: Genistein upregulates tumor suppressor microRNA-574-3p in
prostate cancer. PLoS One. 8:e589292013. View Article : Google Scholar
|
25
|
An J, Pan Y, Yan Z, et al: MiR-23a in
Amplified 19p13.13 loci targets metallothionein 2A and promotes
growth in gastric cancer cells. J Cell Biochem. 114:2160–2169.
2013. View Article : Google Scholar : PubMed/NCBI
|
26
|
Grosso S, Doyen J, Parks SK, et al:
MiR-210 promotes a hypoxic phenotype and increases radioresistance
in human lung cancer cell lines. Cell Death Dis. 4:e5442013.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Kang SM, Lee HJ and Cho JY: MicroRNA-365
regulates NKX2-1, a key mediator of lung cancer. Cancer Lett.
335:487–494. 2013. View Article : Google Scholar : PubMed/NCBI
|
28
|
Miao LJ, Huang SF, Sun ZT, et al: MiR-449c
targets c-Myc and inhibits NSCLC cell progression. FEBS Lett.
587:1359–1365. 2013. View Article : Google Scholar : PubMed/NCBI
|
29
|
Hodak E, Gottlieb AB, Anzilotti M and
Krueger JG: The insulin-like growth factor 1 receptor is expressed
by epithelial cells with proliferative potential in human epidermis
and skin appendages: correlation of increased expression with
epidermal hyperplasia. J Invest Dermatol. 106:564–570. 1996.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Wraight CJ, White PJ, McKean SC, et al:
Reversal of epidermal hyperproliferation in psoriasis by
insulin-like growth factor I receptor antisense oligonucleotides.
Nat Biotechnol. 18:521–526. 2000. View
Article : Google Scholar : PubMed/NCBI
|